Skip to main content
Clinical Trials/CTRI/2022/05/042936
CTRI/2022/05/042936
Recruiting
未知

Multiomics approach to identify early detection biomarkers - A multi cancereffort in India

Strand Life Sciences Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Strand Life Sciences Private Limited
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with confirmed malignant and benign neoplasms who are eligible for surgical resection, chemotherapy or radiation treatments, as identified by the site Principal Investigator or Co\-Investigators through routine clinical care processes.
  • 2\. Age\- 18 years and above.
  • 3\. Patients must have normal laboratory criteria as defined below:
  • â?? Platelets \>100,000/mcL
  • â?? PTT as per institutional limits
  • â?? INR as per institutional limits
  • 4\. Patients who have not undergone any oncosurgery.
  • 5\. Patients who are treatment\-naïve.
  • 6\. Both men and women of all races and ethnic groups are eligible for this study.
  • 7\. Ability to understand and the willingness to sign a written Informed Consent Form.

Exclusion Criteria

  • 1\. Subjects who have undergone prior chemotherapy, targeted therapy or radiation therapy
  • 2\. Subjects with recurrent or relapse cases
  • 3\. Patients who have an uncontrolled infection
  • 4\. Patients who are receiving any oncology investigational agent(s)
  • 5\. Patients who are coagulopathic and are taking blood thinning products
  • 6\. Women who are pregnant or suspect they are pregnant and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials